Company Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris 04:02:41 2024-03-19 am EDT 5-day change 1st Jan Change
87.87 EUR -0.15% Intraday chart for Sanofi -0.46% -2.04%

Business Summary

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (71.4%): prescription drugs in the areas of specialty medicine (54.7% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (16.8%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (11.8%).

At the end of 2022, the group had 59 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.3%), Europe (18%), the United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and other (19.5%).

Number of employees: 86,088

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharma
88.0 %
30,688 71.4 % 37,890 88.0 % +23.47%
Consumer Healthcare
12.0 %
5,080 11.8 % 5,180 12.0 % +1.97%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
43.0 %
18,275 42.5 % 18,512 43.0 % +1.30%
Rest of the World
26.1 %
8,386 19.5 % 11,254 26.1 % +34.20%
Europe
18.6 %
7,703 17.9 % 8,013 18.6 % +4.02%
China
6.8 %
3,123 7.3 % 2,912 6.8 % -6.76%
France
5.5 %
2,296 5.3 % 2,379 5.5 % +3.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 59 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Chief Operating Officer 39 21-12-31
Chief Tech/Sci/R&D Officer 51 -
Chief Tech/Sci/R&D Officer 49 23-09-10
Chief Tech/Sci/R&D Officer - 18-12-31
Public Communications Contact - -
Investor Relations Contact - 20-06-30
Human Resources Officer 53 20-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 14-04-30
Director/Board Member 62 20-04-27
Director/Board Member 64 20-05-21
Chairman 60 22-09-01
Director/Board Member 52 20-04-27
Director/Board Member 66 22-05-02
Director/Board Member 52 22-05-02
Chief Executive Officer 56 19-08-31
Director/Board Member 58 19-04-29
Director/Board Member 64 22-05-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,264,799,969 1,110,144,426 ( 87.77 %) 13,450,388 ( 1.063 %) 87.77 %

Shareholders

NameEquities%Valuation
L'ORÉAL
9.348 %
118,227,307 9.348 % 11 245 M €
Amundi Asset Management SA (Investment Management)
2.458 %
31,087,580 2.458 % 2 957 M €
Dodge & Cox
1.780 %
22,512,304 1.780 % 2 141 M €
Crédit Mutuel Asset Management SA
1.113 %
14,070,956 1.113 % 1 338 M €
SANOFI
0.9642 %
12,195,470 0.9642 % 1 160 M €
Lyxor International Asset Management SAS
0.5764 %
7,289,777 0.5764 % 693 M €
Predica Prévoyance Dialogue du Crédit Agricole SA (Invt Port)
0.5390 %
6,817,764 0.5390 % 648 M €
Groupe des Assurances du Crédit Mutuel SA
0.5066 %
6,406,902 0.5066 % 609 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.4712 %
5,959,127 0.4712 % 567 M €
Fédéral Finance Gestion SA
0.4043 %
5,113,162 0.4043 % 486 M €
NameEquities%Valuation
Dodge & Cox
3.093 %
78,250,193 3.093 % 3 744 M €
Fidelity Management & Research Co. LLC
0.8056 %
20,379,166 0.8056 % 975 M €
Fisher Asset Management LLC
0.5649 %
14,290,391 0.5649 % 684 M €
Boston Partners Global Investors, Inc.
0.5152 %
13,032,746 0.5152 % 624 M €
Merrill Lynch International
0.4056 %
10,260,690 0.4056 % 491 M €
Eaton Vance Management
0.3111 %
7,868,480 0.3111 % 377 M €
Invesco Advisers, Inc.
0.2735 %
6,919,101 0.2735 % 331 M €
BNY Mellon Investment Adviser, Inc.
0.2452 %
6,203,752 0.2452 % 297 M €
BlackRock Investment Management LLC
0.2165 %
5,477,302 0.2165 % 262 M €
Lee Munder Investments Ltd.
0.1844 %
4,663,598 0.1844 % 223 M €

Holdings

NameEquities%Valuation
13,909,587 60.40% 1,445,172,845 $
12,195,470 0.96% 1,159,913,103 $
EUROAPI
29.77%
28,298,074 29.77% 117,897,700 $
4,697,737 7.39% 28,985,037 $
1,919,455 7.30% 6,391,785 $
3,860,600 0.66% 2,633,315 $
29,249 0.12% 546,310 $

Company contact information

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com
address Sanofi(SAN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Aventis, Inc.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
88 EUR
Average target price
107.6 EUR
Spread / Average Target
+22.30%
Consensus